Erratum: Involvement of β-arrestins in cancer progression (Molecular Biology Reports DOI:10.1007/s11033-012-2148-0);Involvement of β-arrestins in cancer progression

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1065-1071

  Hu, Shanshan ^a   Wang, Di ^a   Wu, Jingjing ^a   Jin, Juan ^a   Wei, Wei ^a   Sun, Wuyi ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adapter protein; Cancer; G protein coupled Receptors; Arrestins

Indexed keywords

BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; COLORECTAL CANCER; DISEASE MARKER; HUMAN; LUNG CANCER; NONHUMAN; OVARY CANCER; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

EID: 84878374972     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2337-x     Document Type: Erratum

References (50)

1. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ (2009) Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 17:443-458
2. Luttrell LM, Lefkowitz RJ (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:455-465
3. Gurevich EV, Gurevich VV (2006) Arrestins: ubiquitous regulators of cellular signaling pathways. Genome Biol 7:236
4. Lefkowitz RJ, Whalen EJ (2004) Beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 16:162-168
5. Marchese A, Chen C, Kim YM, Benovic JL (2003) The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci 28:369-376
6. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG (2000) The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. J Biol Chem 275:23120-23126
7. Prossnitz ER (2004) Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors. Life Sci 75:893-899
8. Claing A, Laporte SA, Caron MG, Lefkowitz RJ (2002) Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol 66:61-79
9. Chun KS, Lao HC, Trempus CS, Okada M, Langenbach R (2009) The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development. Carcinogenesis 30:1620-1627
10. Alvarez CJ, Lodeiro M, Theodoropoulou M, Camina JP, Casanueva FF, Pazos Y (2009) Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocr Relat Cancer 16:599-611
11. Rosano L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A et al (2009) Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci USA 106:2806-2811
12. Bryja V, Gradl D, Schambony A, Arenas E, Schulte G (2007) Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc Natl Acad Sci USA 104:6690-6695
13. Bryja V, Schambony A, Cajanek L, Dominguez I, Arenas E, Schulte G (2008) Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep 9:1244-1250
14. Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, Artavanis-Tsakonas S (2005) Regulation of Notch signalling by non-visual beta-arrestin. Nat Cell Biol 7:1191-1201
15. Luan B, Zhao J, Wu H, Duan B, Shu G, Wang X et al (2009) Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457:1146-1149
16. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH et al (2003) The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278:6258-6267
17. Wilbanks AM, Fralish GB, Kirby ML, Barak LS, Li YX, Caron MG (2004) Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science 306:2264-2267
18. Finger EC, Lee NY, You HJ, Blobe GC (2008) Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation. J Biol Chem 283:34808-34818
19. Mythreye K, Blobe GC (2009) The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci USA 106:8221-8226
20. You HJ, How T, Blobe GC (2009) The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. Carcinogenesis 30:1281-1287
21. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della RG et al (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283:655-661
22. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M et al (2005) Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65:6275-6281
23. Zhang Y, Liu Q, Zhang M, Yu Y, Liu X, Cao X (2009) Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J Immunol 182:3801-3808
24. Alaa M, Suzuki M, Yoshino M, Tian L, Suzuki H, Nagato K et al (2009) Prostaglandin E2 receptor 2 overexpression in squamous cell carcinoma of the lung correlates with p16INK4A methylation and an unfavorable prognosis. Int J Oncol 34:805-812
25. Zheng Y, Ritzenthaler JD, Sun X, Roman J, Han S (2009) Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1. Cancer Res 69:896-904
26. Zhu YM, Azahri NS, Yu DC, Woll PJ (2008) Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 8:218
27. Yang L, Huang Y, Porta R, Yanagisawa K, Gonzalez A, Segi E et al (2006) Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism. Cancer Res 66:9665-9672
28. Kim JI, Lakshmikanthan V, Frilot N, Daaka Y (2010) Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. Mol Cancer Res 8:569-577
29. Dasgupta P, Rizwani W, Pillai S, Davis R, Banerjee S, Hug K et al (2011) ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors. J Natl Cancer Inst 103:317-333
30. Raghuwanshi SK, Nasser MW, Chen X, Strieter RM, Richardson RM (2008) Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 180:5699-5706
31. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203-213
32. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN (2006) Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci USA 103:1492-1497
33. Rosano L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG et al (2005) Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res 65:11649-11657
34. Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, Hempel N et al (2007) The type III TGF-beta receptor suppresses breast cancer progression. J Clin Invest 117:206-217
35. Turley RS, Finger EC, Hempel N, How T, Fields TA, Blobe GC (2007) The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Cancer Res 67:1090-1098
36. Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC (2008) Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 29:252-262
37. Amling CL (2001) Diagnosis and management of superficial bladder cancer. Curr Probl Cancer 25:219-278
38. Kelley-Hickie LP, Kinsella BT (2006) Homologous desensitization of signalling by the beta (beta) isoform of the human thromboxane A2 receptor. Biochim Biophys Acta 1761:1114-1131
39. Moussa O, Ashton AW, Fraig M, Garrett-Mayer E, Ghoneim MA, Halushka PV et al (2008) Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Res 68:4097-4104
40. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45
41. Lakshmikanthan V, Zou L, Kim JI, Michal A, Nie Z, Messias NC et al (2009) Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc Natl Acad Sci USA 106:9379-9384
42. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C (2002) Phosphorylation- dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 21:4037-4048
43. Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Clezardin P, Peyruchaud O (2006) The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc Natl Acad Sci USA 103:9643-9648
44. Hao F, Tan M, Xu X, Han J, Miller DD, Tigyi G et al (2007) Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Biochim Biophys Acta 1771:883-892
45. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit LM et al (2009) Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 7:1064-1077
46. Zhao M, Zhou G, Zhang Y, Chen T, Sun X, Stuart C et al (2009) beta-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways. Neoplasma 56:108-113
47. Lundgren K, Tobin NP, Lehn S, Stal O, Ryden L, Jirstrom K et al (2011) Stromal expression of beta-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer. J Mol Diagn 13:340-351
48. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S et al (2002) Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J Biol Chem 277:37693-37701
49. Wang P, Wu Y, Ge X, Ma L, Pei G (2003) Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 278:11648-11653
50. Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M et al (2005) A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123:833-847